Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect

Clinical trial NCT01072162 · COMPLETED

Trial details

NCT number: NCT01072162
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2010-01-12
Primary completion: 2010-04-07
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.